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This article reports a rare case of cancer derived from ovarian remnant tissue. A 52-year-old woman, with
a history of a total hysterectomy and bilateral salpingo-oophorectomy for uterine myomas and endo-
metriosis 13 years ago, presented with a pelvic mass accompanied by high serum levels of CA125 and
CA199. Exploratory laparotomy and pathology report revealed an ovarian serous tumor with low ma-
lignant potential. Cancer derived from ovarian remnant tissue is extremely rare. However, a malignancy
may still originate from the ovarian remnant. Ovarian remnant syndrome after oophorectomy and its
possibility of malignancy, especially in case of endometriosis, should not be neglected.
Copyright © 2014, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Ovarian remnant syndrome (ORS) was a ﬁnding of histologically
residual ovarian tissue after a bilateral salpingo-oophorectomy
(BSO).1 ORS may be present with a normal ovary or ovary-related
diseases, such as the recurrence of disease or the occurrence of a
malignancy, which might contribute to some complications.2 In
addition, because ORS is often neglected, it can produce a diag-
nostic dilemma and therapeutic challenge.3 We report a case of
ovarian cancer diagnosed 13 years after total hysterectomy (TH)
and BSO were carried out.
Case report
A 52-year-old woman had previously undergone a TH and BSO
for severe dysmenorrhea and continuous pelvic pain, which were
secondary to uterine myomas and endometriosis at age 39 years.
The patient denied any other previous medical or surgical illness, ore no conﬂicts of interest.
and Gynecology, Taipei Med-
ty, 252 Wusing Street, Sinyi
for Gynecologic Endoscopy and Minimhaving received any hormone therapy. Ultrasound and computed
tomography (Fig. 1) revealed an 11-cm cystic pelvic mass with a
solid component and rich vascularity. Upper and lower gastroin-
testinal endoscopy failed to demonstrate any abnormalities. How-
ever, she was found to have elevated serum levels of CA-125
(995.3 mIU/mL) and CA-199 (617 mIU/mL).
We performed an exploratory laparotomy and found a >10-cm
mass completely occupying the cul-de-sac with dense adhesion
surrounding the tumor. After careful and meticulous dissection, the
tumorwas completely removed (Fig. 2). The ﬁnal pathology revealed
the diagnosis of an ovarian serous tumor of low malignant potential
(Fig. 3), based on the morphological diagnosis and the assistance of
immunohistochemistry, including the positive presence of ovarian
stromal tissues within the tumor (Fig. 4), negative staining for cal-
retinin, cytokeratin 5/6, and thrombomodulin, and positive staining
for the estrogen and progesterone receptors. The patient is now
undergoing regular follow up. No further adjuvant therapy was
administered, and thepatient remainswell at the timeof submission.Discussion
If there is a suspicion of ORS, the following strategies can be
used to facilitate a diagnosis: including checking serum levels ofally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Postcontrast computed tomographic scan of the pelvis showing a large, cystic,
hypodense, heterogeneous, nonenhanced mass (white arrow) measuring about
110 mm  100 mm  85 mm contiguous with the sigmoid colon. There is no deﬁnitely
enlarged sidewall lymph node.
Fig. 3. Focal stratiﬁcation and tufting of epithelial cells with a micropapillary pattern
noted in areas of the tumor. No stromal invasion can be seen.
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stimulate ovary growth; and evaluating ﬁnal images.4 Ultrasound
and ovulation-inducing drugs are the most economical and
convenient tools for diagnosing ORS in premenopausal women.5
The main cause of ORS is secondary to the incomplete removal of
one or both ovaries. Surgical difﬁculty contributes to the incom-
plete removal, including disease itself, such as endometriosis, or
any inﬂammatory or surgical process; and problems related to the
surgical techniques.6,7 To avoid ORS, the main principle is clear
identiﬁcation and the complete removal of the ovary tissue during
the surgical procedure.
ORS seldom causes severe sequelae, but the majority of patients
suffer from chronic pelvic pain and recurrence of diseases. How-
ever, severe life-threatening diseases may also occur. Cancersmight
be the most serious sequelae, and mostly were malignancies.2,8e10
This leads to an idea that oophorectomy may not comprehensively
protect against the subsequent development of ovarian carcinoma.8Fig. 2. Excision of the tumor by exploratory laparotomy revealing cystic tissue frag-
ments with a gray, smooth external surface.In addition, half of the cases had a history of endometriosis. The
patient in this report also had a history of endometriosis, but was
complicated by the borderline malignancy. This is believed to be
the ﬁrst documented case of a serous tumor of low malignant po-
tential arising from an ovarian remnant.
Distinguishing between an epithelioid peritoneal mesothelioma
and papillary serous carcinomas involving the peritoneum may be
very difﬁcult due to overlapping morphological features.11 If
ovarian stromal tissue exists in the tumor, an ovarian origin is
favored. However, sometimes it is not easy to ﬁnd the ovarian
stromal tissue. Therefore, immunohistochemistry using several
markers may facilitate establishing a correct diagnosis.11 In this
study, we used ﬁve markers to aid in the diagnosis. Because this
tumor was negative for calretinin, cytokeratin 5/6, and thrombo-
modulin, but positive for estrogen and progesterone receptors, a
diagnosis of a serous ovarian tumor was made.
The possibility of the disease is very often overlooked in patients
with previous oophorectomy. Similar to other ovarian tumor, ORS is
very often asymptomatic and probably mostly being suspected
when a pelvic tumor is found in imaging. ORS should be suspected
when patients with previous oophorectomy developed pelvic pain,Fig. 4. Microscopic picture showing a multicystic neoplasm composed of numerous
variably sized cysts or torturous glandular structures lined by single-layered epithe-
lioid to ﬂat lining epithelia among the ovarian stroma.
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As a result, regular checkup and CA125 monitoring in patients with
BSO for endometriosis in early detection of ORS might be
considerable.
Conclusion
The point of interest in this case was the difﬁculty and challenge
of the clinical diagnosis (TH and BSO),12 because ORS associated
with other diseases is frequently and easily neglected. Physicians
sometimes overlook this possibility when awoman presents with a
pelvic mass after a TH and BSO for benign diseases, therefore
ovarian diseases should be kept in mind in the differential
diagnosis.
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